1-4 of 4
F Swan
Close
Sort by
Journal Articles

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

J. Rodriguez, M.A. Rodriguez, L. Fayad, P. McLaughlin, F. Swan, A. Sarris, J. Romaguera, B. Andersson, F. Cabanillas, F.B. Hagemeister
Journal: Blood
Blood (1999) 93 (11): 3632–3636.
https://doi.org/10.1182/blood.V93.11.3632
Published: 1999
Journal Articles

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy

WS Velasquez, LM Fuller, S Jagannath, SL Tucker, LB North, FB Hagemeister, P McLaughlin, F Swan, JR Redman, MA Rodriguez
Journal: Blood
Blood (1991) 77 (5): 942–947.
https://doi.org/10.1182/blood.V77.5.942.942
Published: 1991
Journal Articles

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

WS Velasquez, S Jagannath, SL Tucker, LM Fuller, LB North, JR Redman, F Swan, FB Hagemeister, P McLaughlin, F Cabanillas
Journal: Blood
Blood (1989) 74 (2): 551–557.
https://doi.org/10.1182/blood.V74.2.551.551
Published: 1989
Journal Articles

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez, F Cabanillas, P Salvador, P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan
Journal: Blood
Blood (1988) 71 (1): 117–122.
https://doi.org/10.1182/blood.V71.1.117.117
Published: 1988